AMPHOTERICIN B
ANTIFUNGALS-SYSTEMIC·FUNGAL SEPSIS·+22
X-GEN PHARMACEU
Indication
Leishmaniasis
Leishmaniasis is a vector-borne infectious disease caused by intracellular protozoan parasites of the genus *Leishmania*, transmitted to humans through the bites of infected female phlebotomine sandflies. Read more about Leishmaniasis
5 drugs 5 manufacturers
Drugs that treat it
Common Leishmaniasis therapies.
ABELCET (amphotericin B lipid complex)
FUNGAL SEPSIS·+22
SIGMA-TAU
IMPAVIDO (miltefosine)
ANTIPROTOZOAL AGENTS·VISCERAL LEISHMANIASIS·+2
PROFOUNDA, INC
ABELCET (amphotericin B lipid complex)
FUNGAL SEPSIS·+22
SIGMA-TAU/LEADI
IMPAVIDO (miltefosine)
ANTIPROTOZOAL AGENTS·VISCERAL LEISHMANIASIS·+2
ETON PHARMACEUT
Filter & compare in the drug finder →Opens the drug finder with Leishmaniasis preselected.
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonLeishmaniasis is a vector-borne infectious disease caused by intracellular protozoan parasites of the genus *Leishmania*, transmitted to humans through the bites of infected female phlebotomine sandflies.
The condition primarily impacts the reticuloendothelial system, skin, and mucous membranes, manifesting across three main clinical presentations: cutaneous, mucosal, and visceral leishmaniasis.
Cutaneous disease is characterized by chronic, ulcerating papules or nodules that often leave disfiguring scars, while mucosal forms cause progressive destruction of the naso-oropharyngeal architecture.
Visceral leishmaniasis, or kala-azar, represents the most severe systemic form and is distinguished by prolonged fever, cachexia, hepatosplenomegaly, and pancytopenia due to parasite dissemination throughout the liver, spleen, and bone marrow.
- cdc.gov
Leishmaniasis is a vector-borne infectious disease caused by intracellular protozoan parasites of the genus *Leishmania*, transmitted to humans through the bites of infected female phlebotomine sandflies
- nih.gov
Leishmaniasis is a vector-borne infectious disease caused by intracellular protozoan parasites of the genus *Leishmania*, transmitted to humans through the bites of infected female phlebotomine sandflies
- who.int
Leishmaniasis is a vector-borne infectious disease caused by intracellular protozoan parasites of the genus *Leishmania*, transmitted to humans through the bites of infected female phlebotomine sandflies The condition primarily impacts the reticuloendothelial system, skin, and mucous membranes, manifesting across three main clinical presentations: cutaneous, mucosal, and visceral leishmaniasis
- cdc.gov
The condition primarily impacts the reticuloendothelial system, skin, and mucous membranes, manifesting across three main clinical presentations: cutaneous, mucosal, and visceral leishmaniasis Visceral leishmaniasis, or kala-azar, represents the most severe systemic form and is distinguished by prolonged fever, cachexia, hepatosplenomegaly, and pancytopenia due to parasite dissemination throughout the liver, spleen, and bone marrow
- parasiteswithoutborders.com
The condition primarily impacts the reticuloendothelial system, skin, and mucous membranes, manifesting across three main clinical presentations: cutaneous, mucosal, and visceral leishmaniasis Visceral leishmaniasis, or kala-azar, represents the most severe systemic form and is distinguished by prolonged fever, cachexia, hepatosplenomegaly, and pancytopenia due to parasite dissemination throughout the liver, spleen, and bone marrow
- cdc.gov
Cutaneous disease is characterized by chronic, ulcerating papules or nodules that often leave disfiguring scars, while mucosal forms cause progressive destruction of the naso-oropharyngeal architecture Visceral leishmaniasis, or kala-azar, represents the most severe systemic form and is distinguished by prolonged fever, cachexia, hepatosplenomegaly, and pancytopenia due to parasite dissemination throughout the liver, spleen, and bone marrow
- who.int
Cutaneous disease is characterized by chronic, ulcerating papules or nodules that often leave disfiguring scars, while mucosal forms cause progressive destruction of the naso-oropharyngeal architecture
Personalize your experience
Follow Leishmaniasis and get updates as they land.
Create a free account
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.